Emasan AG
Overview
Emasan AG is a Swiss family office associated with the Sandoz family, focusing on strategic investments across various sectors and stages. The firm is known for its significant stake in Novartis AG, a global leader in pharmaceuticals and healthcare. In February 2025, Emasan AG sold a portion of its Novartis shares, realizing approximately 2.6 billion Swiss francs. This transaction underscores the firm's active role in managing and optimizing its investment portfolio. Emasan AG's investment philosophy emphasizes diversification and long-term value creation, reflecting the Sandoz family's commitment to sustainable growth and innovation. The firm's strategic approach involves identifying and supporting companies with strong growth potential, particularly in the healthcare and technology sectors, aligning with the family's legacy in the pharmaceutical industry. Through its investments, Emasan AG aims to contribute to advancements in healthcare and related industries, leveraging its expertise and resources to foster innovation and improve patient outcomes. The firm's activities are guided by a commitment to ethical investment practices and a focus on creating positive societal impact, consistent with the values upheld by the Sandoz family over generations.
Investment Focus
- Established companies with proven business models
- Strong management teams
- Potential for significant growth
- Alignment with the Sandoz family's values and legacy
Portfolio Companies
Reach Emasan AG directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Emasan AG
What sectors does Emasan AG invest in?
Emasan AG invests in Financial Services, Technology, Healthcare, Energy, Consumer Goods and Real Estate, and is based in Basel-Stadt, Switzerland. Emasan AG is listed as a family office in the ConnectSafely investor database.
What stage does Emasan AG invest at?
Emasan AG backs companies at Early Stage, Growth, Late Stage, Pre-IPO and Buyout.
Which regions does Emasan AG invest in?
Emasan AG invests across United States, United Kingdom, Canada, Germany, Japan and Australia.
What companies has Emasan AG invested in?
Emasan AG's portfolio includes Johnson & Johnson, Merck & Co., Eli Lilly and Company, Pfizer Inc., Bristol-Myers Squibb, Novartis AG, Gilead Sciences and AstraZeneca.
Last updated · Source: ConnectSafely investor database
